Leaderboard

En | De
Sie sind hier: Onkologie » Respirationstrakt 04. Juni 2026
Suchen
medline.ch
Respirationstrakt
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 7962  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 159225  
   
Pre-treatment quality of life and survival outcomes in lung cancer patients: a systematic review and meta-analysis.
Support Care Cancer
Avizova Z, Myssayev AO, Iztleuov YM, Mussin NM, Tamadon A.
PMID: 42240738 [PubMed - in process]


Cost-Effectiveness Analysis of Anamorelin and Olanzapine for Cancer Cachexia in Non-Small Cell Lung Cancer Patients in Japan.
Value Health Reg Issues
Kashiwa M, Nishikawa T.
PMID: 42240544 [PubMed - as supplied by publisher]


Advances in Ommaya reservoir-based intrathecal therapy for leptomeningeal metastasis from non-small cell lung cancer: a systematic review.
Front Oncol
Jiang C, Zhao Y, Chen D, Yuan X.
PMID: 42239892 [PubMed]


Case report: Personalized, response-adapted neoadjuvant alectinib achieves durable remission in stage IIIB ALK-rearranged lung cancer.
Front Pharmacol
Shen H, Huang S, Zhang J.
PMID: 42239517 [PubMed]


A comparative study of oral and gut microbiota for differentiating benign pulmonary nodules from lung cancer.
Front Microbiol
Zhao Z, Zhao S, Liu F, Li G, Hu X, Li L.
PMID: 42238890 [PubMed]


Evaluation of kidney stone-related renal infection status by 18F-FDG PET/CT in lung cancer patients with concomitant nephrolithiasis: a multicenter study.
Front Immunol
Yao X, Ying X, Liu H, Duan C, Li B, Hao Z, Ye Z, Xu H, Mei H, Liu H, Liu J.
PMID: 42238574 [PubMed - in process]


Targeting non-small cell lung cancer: Molecular mechanisms and clinical studies (Review).
Oncol Lett
Luo Y, Yin G, Luo X, Liu Y, Jin K, Wang Z.
PMID: 42238008 [PubMed]


Effectiveness of carboplatin vs cisplatin in lung cancer chemo-immunotherapy: A systematic review and meta-analysis.
Tumori
Leonetti A, Maglietta G, Peroni M, Diodati F, Dodi A, Mazzaschi G, Perrone F, Caminiti C, Tiseo M.
PMID: 42237664 [PubMed - as supplied by publisher]


Landscape of Chinese Lung Cancer Patients With Compound Mutations and Acquired Resistance Alterations: A Retrospective Study.
Int J Cancer
Huang M, Yang J, Peng P, Wang Y, Song L, Lin Y, Zhao J.
PMID: 42237450 [PubMed - as supplied by publisher]


Robotic vs thoracoscopic vs open lobectomy and segmentectomy for lung cancer: a multicenter cohort study in the ATS of Milan.
J Robot Surg
Mazzali C, Buzzoni C, Grignani F, Incarbone MA, Marulli G, Nosotti M, Pariscenti GL, Pastorino U, Spaggiari L, Veronesi G, Russo AG, THOR-ATS (Thoracic Health Outcomes Research) Group.
PMID: 42237053 [PubMed - in process]


A novel ensemble-based genetic algorithm for enhanced feature selection in lung and pancreatic cancer diagnosis.
Discov Oncol
Shabir S, Chishti MA.
PMID: 42237052 [PubMed - as supplied by publisher]


The evolution of non-surgical management in stage III non-small cell lung cancer.
BJC Rep
Patel MS, Hammond A, Dee EC, Iyengar P.
PMID: 42236951 [PubMed]


The predictive value of systemic inflammation response index and albumin-to-globulin ratio for prognosis in non-small cell lung cancer.
Sci Rep
Xu Q, Deng Y, Cai Y, Yu S, Kang M, He F.
PMID: 42236852 [PubMed - as supplied by publisher]


A comprehensive analysis and visualization of immune-related adverse events in lung cancer immunotherapy a bibliometric study.
Discov Oncol
Li X, Zhang F, Xu X.
PMID: 42236618 [PubMed - as supplied by publisher]


Burden of COPD and lung cancer attributable to household air pollution in Morocco: a secondary analysis using population attributable fractions.
BMJ Open
El Harch I, Mahfoudi H, Benmaamar S, Tachfouti N, El Rhazi K.
PMID: 42236099 [PubMed - in process]


Uncertainty quantification framework for AI-based survival models: Application to lung cancer prognosis in older adults for informed decision-making.
Artif Intell Med
Lee D, Tran TN, Jeong J, Kwon H, Cho H.
PMID: 42235349 [PubMed - as supplied by publisher]


Development of a clinical prediction model using digital device data for interstitial lung disease in patients with unresectable stage III non-small cell lung cancer treated with durvalumab.
Lung Cancer
Ikeda S, Kenmotsu H, Koto R, Hirai T, Ogi M, Sato Y, Iwao C, Kitagawa H, Yamamoto N.
PMID: 42235163 [PubMed - as supplied by publisher]


Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.
J Clin Oncol
Doroshow DB, Leal TA, Waqar SN, Borghaei H, Camidge DR, Dragnev KH, Edelman MJ, Gandara DR, Gerber DE, Gray JE, Hirsch FR, Husain H, Kozono DE, Leighl NB, Li BT, Mack PC, Neal JW, Paik PK, Patel SP, Riess JW, Redman MW, Reckamp KL.
PMID: 42234933 [PubMed - as supplied by publisher]


Complex versus simple segmentectomy in non-small cell lung cancer: a single-center, retrospective study.
Gen Thorac Cardiovasc Surg
Seto K, Matsubayashi Y, Noritake O, Matsui T, Suzuki S, Kuroda H, Masago K, Sakakura N.
PMID: 42234389 [PubMed - as supplied by publisher]


Expression levels of microRNA-550a-5p in patients with spinal metastases from non-small cell lung cancer.
Per Med
Guo H, Li J, Li T, Ruan J.
PMID: 42233655 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 159225    Seite 1 von 7962  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1